[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355110-105":59,"doc-detail-355110-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mir-4326-predicts-adverse-outcomes-of-triple-negative-breast-cancer-and-regulates-cell-growth-and-motility-through-modulating-med13","miR-4326 predicts adverse outcomes of triple-negative breast cancer and regulates cell growth and motility through modulating MED13","","Triple-negative breast cancer (TNBC) is a highly malignant subtype with high recurrence and adverse prognosis, and reliable molecular targets remain limited. This study investigated the clinical significance of miR-4326 and its role in tumor progression, aiming to identify a novel biomarker for TNBC. In 108 TNBC patients, miR-4326 expression was assessed by PCR and related to disease severity and 5-year prognosis. In vitro assays evaluated effects on cell growth and motility after transfection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mir-4326-predicts-adverse-outcomes-of-triple-negative-breast-cancer-and-regulates-cell-growth-and-motility-through-modulating-med13/355110/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mir-4326-predicts-adverse-outcomes-of-triple-negative-breast-cancer-and-regulates-cell-growth-and-motility-through-modulating-med13/355110.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study address in TNBC?","Question",{"text":112,"@type":113},"TNBC has high recurrence and an adverse prognosis, while reliable molecular targets for improving outcomes are still lacking in clinical practice.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was miR-4326 evaluated and linked to patient outcomes?",{"text":117,"@type":113},"miR-4326 expression was measured by PCR in TNBC tissue samples, and clinical significance was assessed using disease severity and 5-year prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional role does miR-4326 play in TNBC cells?",{"text":121,"@type":113},"miR-4326 knockdown significantly suppresses TNBC cell proliferation, migration, and invasion, while MED13 shows opposite dysregulation and is negatively regulated by miR-4326.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355110,1790193330,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Wang et al. World Journal of Surgical Oncology (2026) 24:90  \n[https://doi.org/10.1186/s12957-026-04200-1](https://doi.org/10.1186/s12957-026-04200-1)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nmiR-4326 predicts adverse outcomes of triplenegative breast cancer and regulates cell growth and motility through modulating MED13  \nWeina Wang1†, Xinyu Zhang2†, Linna Kong3, Jiaqi Liu3, Huihui Zhang3, Jun Chu3* and Peng Dai4*  \nAbstract  \nBackground Triple-negative breast cancer (TNBC) is one of the most malignant subtypes of breast cancer with a high recurrence rate and adverse prognosis. Due to the lack of reliable molecular targets, improving patients’outcomes is still a challenge in the clinic. The clinical significance of miR-4326 and its potential in mediating tumor progression were investigated in this study, aiming to explore a novel biomarker forTNBC.  \nMethods A total of 108 patients diagnosed with TNBC were included in the present study, and the tissue samples were collected. The expression of miR-4326 was evaluated using PCR, while its clinical significance was assessed from the perspectives of disease severity and 5-year prognosis. In vitro, the regulation ofTNBC cell growth and motility by miR-4326 was evaluated by CCK8 and Transwell assays with the help of cell transfection.  \nResults Upregulation of miR-4326 was observed in tumor tissues ofTNBC patients, which indicates advanced TNM stage, the occurrence of lymph node metastasis, and poorer prognosis. InTNBC cells, miR-4326 was also upregulated, its knockdown significantly suppressed cell proliferation, migration, and invasion. MED13 showed opposite dysregulation and was negatively regulated by miR-4326 . Silencing MED13 could reverse the suppressive effect of miR-4326 knockdown onTNBC cells.  \nConclusions miR-4326 could serve as a prognostic biomarker forTNBC and regulate tumor progression via targeting MED13 .  \nKeywords Tumor monitoring, Prognosis prediction, Severity, Biological function  \n†Weina Wang and Xinyu Zhang should be considered joint first authors.  \n*Correspondence:  \nJun Chu [junchu_dr@163.com](junchu_dr@163.com)[ ](junchu_dr@163.com)Peng Dai [DP13485341526@163.com](DP13485341526@163.com)  \n1Department of Medical Oncology, People’s Hospital of Wuwei, Wuwei City, Gansu Province 733000, China  \n2Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin,  \nHeilongjiang Province 150081, China  \n3Department of Breast and Thyroid Surgery, Zibo Central Hospital, 54 Gongqingtuan West Road, Zibo, Shandong 255020, China 4Department of General Medicine, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, No. 3, Zhigongxincun, Xinghualing District, Taiyuan,  \nShanxi Province 030001, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](veco","cbCaidW4r27q2phV","https://ap.wps.com/l/cbCaidW4r27q2phV","pdf",5268952,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What clinical problem does the study address in TNBC?\",\"answer\":\"TNBC has high recurrence and an adverse prognosis, while reliable molecular targets for improving outcomes are still lacking in clinical practice.\"},{\"question\":\"How was miR-4326 evaluated and linked to patient outcomes?\",\"answer\":\"miR-4326 expression was measured by PCR in TNBC tissue samples, and clinical significance was assessed using disease severity and 5-year prognosis.\"},{\"question\":\"What functional role does miR-4326 play in TNBC cells?\",\"answer\":\"miR-4326 knockdown significantly suppresses TNBC cell proliferation, migration, and invasion, while MED13 shows opposite dysregulation and is negatively regulated by miR-4326.\"}]","miR-4326 predicts adverse outcomes of triple-negative breast cancer and regulates cell growth and motility through modulating MED13 | PDF",1790116068,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/261aca9b1c244f3aa31f92f346637e67.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a1d07425c2aa9efffcf6868f90831e5.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/779e02a876ee7ab3ba4cc9c47cdf062f.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78ef2e8a3a2a28552a25325055a2443c.webp",980,1306]